Kunming Longjin Pharmaceutical Co., Ltd. (002750.SZ)
- Previous Close
1.1300 - Open
1.1800 - Bid --
- Ask 1.1300 x --
- Day's Range
1.1300 - 1.1600 - 52 Week Range
1.1300 - 5.0400 - Volume
11,644,640 - Avg. Volume
9,871,262 - Market Cap (intraday)
452.565M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 23, 2018
- 1y Target Est
--
Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial hemp consumer products. It also engages in the industrial hemp plantation business. Kunming Longjin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Kunming, China.
www.longjin.com.cn--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 002750.SZ
View MorePerformance Overview: 002750.SZ
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002750.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002750.SZ
View MoreValuation Measures
Market Cap
452.56M
Enterprise Value
184.84M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.83
Price/Book (mrq)
0.97
Enterprise Value/Revenue
4.02
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-62.34%
Return on Assets (ttm)
-2.99%
Return on Equity (ttm)
-9.07%
Revenue (ttm)
66.48M
Net Income Avi to Common (ttm)
-41.44M
Diluted EPS (ttm)
-0.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
295.16M
Total Debt/Equity (mrq)
0.75%
Levered Free Cash Flow (ttm)
-8.16M